RATIONALE: Pre-hospital providers have low rates of recognition of atypical anaphylaxis and use of epinephrine as first-line therapy. This study evaluated the effect of two anaphylaxis education interventions for prehospital providers. METHODS: A survey was developed that assessed knowledge and confidence in recognizing and treating anaphylaxis. A narrated online module (OM) about anaphylaxis and treatment with epinephrine was produced for the Columbus Division of Fire (CFD). Simulation (SIM) aimed at recognition of atypical anaphylaxis and early epinephrine administration were conducted at CFD stations. We surveyed CFD providers at baseline, following OM, and following SIM. Pre/post intervention survey responses were compared with difference in means for confidence and knowledge questions and odds ratios (OR) for SIM. Children's Hospital at London Health Science Centre, London, ON, Canada. RATIONALE: We sought to compare characteristics of anaphylaxis between children in the first two years of life and older children up to eighteen years of age. METHODS: Children presenting with anaphylaxis to Emergency Departments (ED) in five Canadian provinces were recruited into the Cross-Canada Anaphylaxis Registry. A standardised form documenting anaphylaxis was completed by research teams. Moderate anaphylaxis was defined by crampy abdominal pain, diarrhea, recurrent vomiting, dyspnea, stridor, cough, wheeze, or ''light-headedness''. Severe anaphylaxis was defined by the presence of cyanosis/hypoxia, respiratory arrest, hypotension, dysrhythmia, confusion, or loss of consciousness. Chisquared tests were used to compare anaphylaxis severity, clinical presentation, management and triggers between younger and older children. RESULTS: Between July 2012 and October 2017 in participating ED's,we recorded 694 cases of anaphylaxis in children less than 2 years and 2117 cases in older children. The median age in younger children was 1 year (Interquartile range (IQR) 0.7-1.5) and older children was 5.5 years (IQR 2.1-11.2). Older children were more likely to have moderate-severe anaphylaxis (82% vs 68%, p50.001), respiratory symptoms (38% vs 29%, p50.001) or be treated with epinephrine (78% vs 68%, p50.0001). Presenting gastrointestinal symptoms were similar in both groups (41% vs 41%). Egg, peanut and milk were the more frequent trigger foods in younger children compared to older children (21% vs 3%, p50.001), (21% vs 18%, p50.09), (10% vs 5%, p50.001) respectively. CONCLUSIONS: Characteristics of anaphylaxis differ between young and older children. These factors may inform clinicians in optimizing management of anaphylaxis presentations in childhood. The Children's Hospital of Philadelphia, Philadelphia, PA. RATIONALE: There is increasing evidence that the majority of pediatric patients presenting with anaphylaxis do not require prolonged observation. We aimed to evaluate the cost-effectiveness of implementing an anaphylaxis algorithm that reduces emergency department (ED) observation time for low-risk patients and provides families with a free epinephrine autoinjector. METHODS: Pre-and post-intervention data from a pediatric hospital implementing this algorithm and additional variables from the literature were incorporated into a decision-analytic cost-utility model from a hospital perspective. We modeled an algorithm providing all individuals with a free epinephrine auto-injector -the most expensive scenario for the hospital. All parameters were varied based on published ranges, or if no ranges were available, 615% of the base value. The primary outcomes were the effect on direct hospital costs and the incremental costeffectiveness ratio (ICER) expressed in 2018 USD per disability-adjusted life year (DALY) averted. The model was subjected to one-way sensitivity and probabilistic uncertainty analyses. RESULTS: For every 1000 patients presenting to the ED with anaphylaxis, use of this algorithm would reduce $208,211 in hospital costs and avert 0.3 DALYs, resulting in an ICER of $692,721 per DALY averted. Results were unchanged in one-way sensitivity analysis. In probabilistic uncertainty analysis, algorithm implementation was cost-effective 95.6% of the time. CONCLUSIONS: Reducing ED observation time decreases hospital costs, hospital charges, and DALYs due to anaphylaxis and being in the hospital. This intervention remains cost-effective despite the added cost of giving all patients a free epinephrine auto-injector.
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